Glenmark Pharmaceuticals gets ₹121.25 crore GST demand, plans to appeal

Share it

On February 7, shares of Glenmark Pharmaceuticals Ltd ended at ₹1,543.35, up by ₹45.15, or 3.01% on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *